Gene Query: IPMK

Dataset Description Geneva Score
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 29.97
Transcriptome analysis in Neobractatin treated cells 24.01
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 23.75
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 23.75
Transcriptomic analysis of LSD1 22.29
RNA expression following TMPRSS11B overexpression or depletion 22.25
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 20.53
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 20.01
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 18.43
Effect of mitochondria deficiency on senescence-associated gene expression 16.36
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 16.1
Gene expression in PANC1 cells treated with Rakicidin 15.49
Hypoxic transcriptome of SQ20B human head and neck cancer cells 15.42
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 14.87
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 14.44
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 14.44
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 14.2
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 13.53
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 13.24
Differentially expressed genes post knock down of lincDUSP26 13.12
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 12.85
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 12.85
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 12.39
Global transcriptome analysis of WT versus HEB-/- hESCs 12.34
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 11.64
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 11.37
SUV420H2 knockdown in PANC-1 11.2
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 11.18
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 10.94
A role for ZNF598 in post-transcriptional gene regulation 10.49
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 10.47
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 10.27
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 10.11
Ebola virus (EBOV) infection of ARPE-19 cells 10.02
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 10.01
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 9.77
Gene expression changes after LOC550643 silencing 9.67
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 9.61
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 9.29
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 9.25
LIN28A modulates splicing and gene expression programs in breast cancer cells 9.25
Identification of Nrf2 regulated genes by RNA sequencing 8.95
Nrf2 regulated genes in A549 cells 8.95
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 8.79
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 8.61
Hijacking of stress response machinery by oncogenes in acute leukaemia 8.52
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 8.52
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 8.51
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 8.33
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 8.33
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.25
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 8.14
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 8.14
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 8.04
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 8.0
Regulation of hypoxia-inducible factor activity by ZMYND8 8.0
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 7.91
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 7.91
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 7.59
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 7.37
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 7.34
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 7.28
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 7.26
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 7.12
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 7.07
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.04
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.96
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.96
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 6.67
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 6.62
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 6.58
Oncogenic MYC induces a dependency on the spliceosome in human cancer 6.55
Effect of PRDM11 depletion in U2932 cells 6.53
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 6.52
AMPK signaling for naïve pluripotency [Hs] 6.5
AMPK signaling for naïve pluripotency 6.5
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 6.47
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 6.46
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 6.41
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 6.41
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 6.4
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 6.4
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 6.38
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 6.38
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 6.37
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 6.32
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 6.27
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 6.17
RNA expression analysis upon JMJD1C depletion 6.17
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 6.12
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 6.07
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 6.02
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 6.0
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 6.0
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 5.91
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 5.9
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.85
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 5.79
Global transcriptome analysis of HAP1 cells 5.78
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.77
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 5.76
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 5.73
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 5.69
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 5.67
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 5.49
PGE2 mediated gene expression changes in human cervical stromal cells 5.4
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.35
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.29
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 5.28
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 5.28
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 5.22
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 5.15
Transcriptomic analysis of ERR alpha orphan nuclear receptor 5.13
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 5.08
RNA-Seq in neutrophils from Antiphospholipid Syndrome 5.05
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 4.86
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 4.84
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 4.84
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 4.74
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.66
The regulartory role of ZCCHC24 in splicing machinery 4.65
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 4.6
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 4.6
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 4.6
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 4.55
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 4.51
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 4.49
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 4.47
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 4.44
The role of CFTR in islet function 4.43
Human embryonic stem cells in E8 and AKIT culture medium 4.4
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 4.4
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 4.39
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 4.32
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 4.2
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 4.17
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 4.13
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 4.13
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 4.13
Targeting MTHFD2 in Acute Myeloid Leukemia 4.11
Gene expression analysis in response to hypoxic pathway inhibition 4.1
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 4.05
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 4.02
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 3.98
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 3.97
NKX2.2 3.97
IL-33 activates tumor stroma to promote intestinal polyposis 3.94
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 3.94
The bromodomain protein BRD4 regulates splicing during heat shock 3.93
An RNA-centric dissection of host complexes controlling flavivirus infection 3.92
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 3.92
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 3.92
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 3.88
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 3.87
Transcriptome of diurnal human blood neutrophils 3.8
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 3.8
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 3.8
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 3.78
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 3.76
Dysregulated immune system networks in war veterans with PTSD 3.73
Noncoding regions are the main source of targetable tumor-specific antigens 3.7
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 3.69
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 3.68
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 3.68
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 3.66
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 3.66
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 3.64
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 3.64
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 3.63
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 3.63
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 3.62
Mapping interactions for the TNIP2 hub protein 3.59
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.55
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.51
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 3.49
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.42
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 3.37
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.37
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 3.31
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 3.31
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 3.31
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 3.3
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 3.3
Knockdown of ADNP in HCT116 colon cancer cells 3.3
Gene expressions of H9s in different culture systems 3.29
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 3.28
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 3.27
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 3.26
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 3.25
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 3.25
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 3.23
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 3.2
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.19
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 3.19
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 3.18
Cell responses to dysregulated VZV-induced cell-cell fusion 3.17
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.09
Gene expression profiling of leukemia cells following asparagine depletion 3.08
Zone dependent distinctive gene expression profile of the normal human liver tissue 3.08
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 3.05
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 3.05
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 3.05
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 3.04
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 3.02
Intron retention induced by microsatellite expansions as a disease biomarker. 3.01
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 2.99
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.98
Gene expression changes due to PARP knockdown in human cells 2.98
Altering cancer transcriptomes using epigenomic inhibitors 2.97
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 2.97
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 2.95
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.94
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.94
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 2.93
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 2.92
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.92
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.92
Exploring ILF2 regulatory genes by next-generation sequencing 2.92
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 2.91
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 2.9
The cohesin release factor WAPL restricts chromatin loop extension. 2.89
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.89
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.87
Next generation sequencing of small RNAs isolated from exosomes in human semen 2.87
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 2.86
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 2.85
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 2.84
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 2.84
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.82
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.8
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  2.79
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 2.78
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.78
Ribosomal footprinting of CN34-Parental and CN34-LM1a 2.77
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.76
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.75
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 2.75
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 2.73
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 2.73
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 2.72
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 2.71
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.69
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.69
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 2.68
Ribosomal footprinting of MDA-Parental and MDA-LM2 2.67
Total RNA sequencing of APC mutant and wt colonic organoids 2.67
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 2.66
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 2.64
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 2.64
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 2.61
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 2.6
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 2.6
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 2.6
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.59
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 2.59
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 2.57
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 2.54
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.53
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.53
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.48
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 2.47
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.47
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.47
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 2.46
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 2.46
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 2.45
PNET animal model: new insights (II) 2.43
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 2.42
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.4
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 2.4
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 2.4
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 2.39
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 2.34
TGF-β regulation of miRNA expression in pancreatic cancer 2.33
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.32
High-Throughput Kinetic Analysis of Fractional Killing 2.31
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.31
Landscape and variation of RNA secondary structure across the human transcriptome 2.31
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.27
Illumina Total RNA-seq in HeLa 2.27
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.26
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 2.22
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.22
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.22
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 2.22
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 2.22
Transcriptomes of human monocytes after ex vivo exposure to uric acid 2.21
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.21
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 2.21
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 2.2
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 2.19
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 2.19
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.16
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 2.15
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 2.12
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 2.12
Expression data from miR340 overexpressing human A549 cells 2.05
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 2.04
Mitochondrial dsRNA triggers antiviral signalling in humans 2.02
Mechanistic Model-Guided Study of Embryonic Morphogenesis 2.02
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 2.01
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.96
ARID1A and ARID1B loss in HCT116 and TOV21G cells 1.95
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 1.93
LncRNA expression profiling of ischemic stroke patients 1.92
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.92
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 1.92
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.92
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.9
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 1.9
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.87
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 1.86
Transcriptional profiling of LS1034 cells treated with tepoxalin 1.85
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.82
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 1.79
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.79
WRN knockout effects upon gene expression in SW48 and OVK18 1.78
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.78
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 1.76
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 1.76
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.75
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 1.74
RNA seq analysis of human Fetal and adult derived Enterospheres 1.73
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.72
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 1.7
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.7
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.69
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 1.69
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 1.68
Human neutrophil genome during PMA- and E. coli encounter-induced activation 1.68
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.67
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.67
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.66
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 1.65
Clinker: visualizing fusion genes detected in RNA-seq data 1.65
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 1.65
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 1.63
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.61
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 1.6
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.59
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.57
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.56
Common inflammatory pathways between NEC and Crohn's disease 1.56
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 1.54
Lineage specific differentiation is influenced by state of human pluripotency 1.54
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 1.54
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 1.53
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.52
Transcriptome-wide response to synthetic chromatin protein PcTF 1.51
Tpl-2 small molecule project 1.49
Tpl-2 and MEK small molecule inhibitors 1.49
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 1.48
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 1.48
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 1.47
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 1.47
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 1.46
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.46
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.46
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.46
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 1.44
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.42
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.42
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.42
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.4
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 1.39
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 1.38
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 1.34
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.32
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 1.3
Trascriptome of thyroid cancer-induced macrophages 1.29
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.24
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.23
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.23
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 1.23
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 1.19
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.18
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 1.18
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 1.18
Transcriptome analysis of peripheral blood monocytes 1.17
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.17
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.16
STX4 Over-Expression in Human islets 1.16
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 1.16
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 1.15
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 1.15
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.13
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.12
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.11
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 1.11
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 1.1
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 1.1
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.09
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.08
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.08
Loss of CREBBP results in gene expression repression in lymphoma cells 1.08
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 1.07
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.07
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 1.06
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.01
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 0.99
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.99
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.97
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 0.97
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.95
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.95
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 0.94
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 0.94
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 0.91
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 0.91
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.9
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.89
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 0.88
Transcriptional landscape changes during human embryonic stem cell derivation 0.86
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.86
Oncogenic roles of ARID5B in T-ALL 0.86
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 0.84
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.84
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 0.83
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.82
Deep RNA sequencing of the human placental transcriptome 0.82
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 0.82
Dermal endothelial cells of type 2 diabetic patients 0.81
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.8
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.8
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.8
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.77
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.75
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.74
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.73
The contribution of Alu exons to the human proteome 0.7
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.69
Reprogrammed myeloid cell transcriptomes in NSCLC 0.68
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 0.68
RNA Seq of HMVEC under hypoxia 0.68
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.68
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.65
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 0.64
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 0.64
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.64
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.64
RNA-seq analysis of control and Myc-induced U2OS cells 0.61
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.6
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.58
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.58
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 0.56
Transcriptome-wide modulation of splicing by the exon junction complex 0.52
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.52
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.51
RNA-seq of primary patient AML samples 0.51
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.5
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.49
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.48
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.48
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.47
The transcriptome of Kawasaki Disease arteritis 0.46
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.45
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.42
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.42
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.4
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.36
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.34
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.34
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 0.33
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.31
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 0.31
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.3
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.29
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.28
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.28
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.26
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.25
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.24
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.24
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.24
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 0.23
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.22
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.18
Modulation of nonsense-mediated decay by rapamycin 0.17
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.16
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.13
MAIT cell RNA sequencing 0.13
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.13
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.12
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.12
RNAseq of Breast cancer PDX samples 0.12
hNSCs siRNA NOVA2 0.11
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.1
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.1
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.09
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.08
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.08
Genome-wide analysis of the Integrator complex 0.06
Genome-wide analysis of the Integrator complex (HTS) 0.06
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 0.05
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.05
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.05
KSDM1b Role in Ewing Sarcoma 0.02
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 0.02
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation